Stock Analysis:INC Research (NASDAQ:INCR) Price Target Change
In analysts report made public by Jefferies & Co on Tuesday morning, INC Research (NASDAQ:INCR) had its PT increased to $53.00. The firm presently has a solid “Buy” rating on shares.
From a total of 7 analysts covering INC Research Holdings (NASDAQ:INCR) stock, 7 rate it a ”Buy”, 0 a “Sell”, and 2 a ”Hold”. This means that 78% of the ratings are positive. The highest target price is $59 while the lowest target price is $39. The mean of all analyst targets is $52.43 with a 20.28% above today’s ($45.52) stock price. INC Research Holdings was the topic of 5 analyst reports since August 14, 2015 according to the firm StockzIntelligence Inc. Suntrust Robinson initiated shares on November 19 with “Buy” rating. Credit Suisse reinitiated INCR stock in a recent report from August 14 with “Outperform” rating.
The stock increased 1.72% or $0.77 during the last trading session, striking $45.52. Approximately shares of stock traded hands. INC Research Holdings Inc (NASDAQ:INCR) has risen 39.89% since May 6, 2015 and is uptrending. It has outperformed by 40.69% the S&P500.
The overall sentiment of institutions has decreased to 3.11 in Q2 2015. Its down 2.26, from 5.37 in 2015Q2. The ratio is negative, as 9 institutions have sold all the shares of INC Research Holdings Inc that they owned while 27 funds have taken shares off the table. 38 funds have purchased shares for the first time while 74 added to their positions. These institutions now hold 92.52 million shares or 43.76% more than the 64.35 million shares they owned in 2015Q2.
The Fund Ontario Teachers Pension Plan Board currently is holding shares equating to 5.41% of its total portfolio in INC Research Holdings Inc representing a total of 14.70 million shares. Another fund,Incline Global Management Llc, is holding a total of 528,673 shares equating to 4.67% of their holdings. Additionally, Timpani Capital Management Llc has a 147,995 share stake in INC Research Holdings Inc which represents 2.39% of their total portfolio. The Fund, Tamro Capital Partners Llc, based out of Virginia, has also built up a stake in the stock, which represents a total of 2.22% of their total portfolio. Finally Copper Rock Capital Partners Llc, a fund which is based in the state of Massachusetts reported a total holdings of 481,796 shares.
INC Research Holdings, Inc. is a global contract research organization . The company has a market cap of $2.39 billion. The Firm is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. It currently has negative earnings. The Company’s segment Clinical Development Services offers a variety of clinical development services, including global studies, clinical monitoring, investigator recruitment, patient recruitment, data management and study reports.
According to Zacks Investment Research, “INC Research Holdings, Inc. is a global contract research organization. It provides the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Its services include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, regulatory and medical writing, and functional service; and data services consisting of clinical data management, electronic data capture, and biostatistics. INC Research Holdings, Inc. is headquartered in Raleigh, North Carolina.” Get a free copy of the Zacks research report on INC Research Holdings Inc (INCR).